Literature DB >> 25884260

Clinical characteristics and long-term outcomes in patients with ruptured posterior inferior cerebellar artery aneurysms: a comparative analysis.

Richard W Williamson1, David A Wilson1, Adib A Abla1, Cameron G McDougall1, Peter Nakaji1, Felipe C Albuquerque1, Robert F Spetzler1.   

Abstract

OBJECT: Subarachnoid hemorrhage (SAH) from ruptured posterior inferior cerebellar artery (PICA) aneurysms is uncommon, and long-term outcome data for patients who have suffered such hemorrhages is lacking. This study investigated in-hospital and long-term clinical data from a prospective cohort of patients with SAH from ruptured PICA aneurysms enrolled in a randomized trial; their outcomes were compared with those of SAH patients who were treated for other types of ruptured intracranial aneurysms. The authors hypothesize that PICA patients fare worse than those with aneurysms in other locations and this difference is related to the high rate of lower cranial nerve dysfunction in PICA patients.
METHODS: The authors analyzed data for 472 patients enrolled in the Barrow Ruptured Aneurysm Trial (BRAT) and retrospectively reviewed vasospasm data not collected prospectively. In the initial cohort, 57 patients were considered angiographically negative for aneurysmal SAH source and did not receive treatment for aneurysms, leaving 415 patients with aneurysmal SAH.
RESULTS: Of 415 patients with aneurysmal SAH, 22 (5.3%) harbored a ruptured PICA aneurysm. Eight of them had dissecting/fusiform-type aneurysms while 14 had saccular-type aneurysms. Nineteen PICA patients were treated with clipping (1 crossover from coiling), 2 were treated with coiling, and 1 died before treatment. When comparing PICA patients to all other aneurysm patients in the study cohort, there were no statistically significant differences in age (mean 57.6 ± 11.8 vs 53.9 ± 11.8 years, p = 0.17), Hunt and Hess grade median III [IQR II-IV] vs III [IQR II-III], p = 0.15), Fisher grade median 3 [IQR 3-3] vs 3 [IQR 3-3], p = 0.53), aneurysm size (mean 6.2 ± 3.0 vs 6.7 ± 4.0 mm, p = 0.55), radiographic vasospasm (53% vs 50%, p = 0.88), or clinical vasospasm (12% vs 23%, p = 0.38). PICA patients were more likely to have a fusiform aneurysm (36% vs 12%, p = 0.004) and had a higher incidence of lower cranial nerve dysfunction and higher rate of tracheostomy/percutaneous endoscopic gastrostomy placement compared with non-PICA patients (50% vs 16%, p < 0.001). PICA patients had a significantly higher incidence of poor outcome at discharge (91% vs 67%, p = 0.017), 1-year follow-up (63% vs 29%, p = 0.002), and 3-year follow-up (63% vs 32%, p = 0.006).
CONCLUSIONS: Patients with ruptured PICA aneurysms had a similar rate of radiographic vasospasm, equivalent admission Fisher grade and Hunt and Hess scores, but poorer clinical outcomes at discharge and at 1- and 3-year follow-up when compared with the rest of the BRAT SAH patients with ruptured aneurysms. The PICA's location at the medulla and the resultant high rate of lower cranial nerve dysfunction may play a role in the poor outcome for these patients. Furthermore, PICA aneurysms were more likely to be fusiform than saccular, compared with non-PICA aneurysms; the complex nature of these aneurysms may also contribute to their poorer outcome.

Entities:  

Keywords:  BRAT = Barrow Ruptured Aneurysm Trial; GOS = Glasgow Outcome Scale; ICU = intensive care unit; IQR = interquartile range; PEG = percutaneous endoscopic gastrostomy; PICA; PICA = posterior inferior cerebellar artery; SAH = subarachnoid hemorrhage; aneurysm; mRS = modified Rankin Scale; outcomes; subarachnoid hemorrhage; vascular disorders

Mesh:

Year:  2015        PMID: 25884260     DOI: 10.3171/2014.10.JNS141079

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  8 in total

1.  Microsurgery and endovascular treatment of posterior inferior cerebellar artery aneurysms.

Authors:  A Sejkorová; F Cihlář; A Hejčl; J Lodin; P Vachata; Martin Sameš
Journal:  Neurosurg Rev       Date:  2015-08-23       Impact factor: 3.042

2.  Flow diverters for the posterior inferior cerebellar artery aneurysms: A systematic review and a single-arm meta-analysis.

Authors:  Xiang Liu; Kunyang Bao; Wenzhang Luo; Weifeng Wan; Tangming Peng; Changren Huang
Journal:  Interv Neuroradiol       Date:  2021-09-14       Impact factor: 1.764

3.  Pipeline embolization of distal posterior inferior cerebellar artery aneurysms.

Authors:  David C Lauzier; Brandon K Root; Yasha Kayan; Josser E Delgado Almandoz; Joshua W Osbun; Arindam R Chatterjee; Kayla L Whaley; Megan E Tipps; Christopher J Moran; Akash P Kansagra
Journal:  Interv Neuroradiol       Date:  2021-04-23       Impact factor: 1.610

4.  Flow diversion via telescoping stent with Low-profile Visualized Intraluminal Support Junior for treatment of ruptured dissecting aneurysm located at proximal posterior inferior cerebellar artery.

Authors:  Hee Kwon Shin; Hae-Won Koo; Moon-Jun Sohn; Yung Ki Park
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2021-06-10

5.  Endovascular treatment of distal posterior inferior cerebellar artery aneurysms.

Authors:  Jun Tang; Linjie Wei; Lin Li; Yin Niu; Qianwei Chen; Hua Feng; Gang Zhu; Zhi Chen
Journal:  Neurosciences (Riyadh)       Date:  2016-07       Impact factor: 0.906

6.  Partial wrap-clipping of the entrance of the pseudolumen of a fusiform aneurysm in the posterior inferior cerebellar artery: a technical note.

Authors:  Yasushi Motoyama; Yoshiaki Takamura; Shuichi Yamada; Young-Su Park; Hiroyuki Nakase
Journal:  Acta Neurochir (Wien)       Date:  2017-01-31       Impact factor: 2.216

7.  Microsurgical Management of Posterior Circulation Aneurysms: A Retrospective Study on Epidemiology, Outcomes, and Surgical Approaches.

Authors:  Wanchun You; Jiahao Meng; Xingyu Yang; Jie Zhang; Guannan Jiang; Zeya Yan; Feng Gu; Xinyu Tao; Zhouqing Chen; Zhong Wang; Gang Chen
Journal:  Brain Sci       Date:  2022-08-11

Review 8.  Clinical Importance of the Posterior Inferior Cerebellar Artery: A Review of the Literature.

Authors:  Hui-Lei Miao; Deng-Yan Zhang; Tao Wang; Xiao-Tian Jiao; Li-Qun Jiao
Journal:  Int J Med Sci       Date:  2020-10-18       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.